Protein interacting with C kinase and neurological disorders

Synapse

Volumn 67, Issue 8, 2013, Pages 532-540

  Focant, Marylène C ^a   Hermans, Emmanuel ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Glutamate receptor; Glutamate transporter; PDZ domain; Trafficking

Indexed keywords

CYSTEINE; DEXTRO SERINE; MEMBRANE PHOSPHOLIPID; PARKIN; PROTEIN INTERACTING WITH PROTEIN KINASE C; RACEMASE; SERINE; UBIQUITIN PROTEIN LIGASE E3; ZINC ION;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CHRONIC PAIN; COCAINE DEPENDENCE; DELUSION; DISEASE ASSOCIATION; DISULFIDE BOND; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; EPILEPSY; HALLUCINATION; MEMBRANE BINDING; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PDZ DOMAIN; POSITIVE SYNDROME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; PSYCHOSIS; SCHIZOPHRENIA; SYNAPSE; THOUGHT DISORDER;

ANIMALS; CARRIER PROTEINS; HUMANS; NERVOUS SYSTEM DISEASES; NUCLEAR PROTEINS; PDZ DOMAINS; RECEPTORS, AMPA; SYNAPSES;

EID: 84879550299     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21657     Document Type: Article

References (83)

1. Ammendrup-Johnsen I, Thorsen TS, Gether U, Madsen KL. 2012. Serine 77 in the PDZ domain of PICK1 is a protein kinase Calpha phosphorylation site regulated by lipid membrane binding. Biochemistry 51:586-596.
2. Arias RL, Sung ML, Vasylyev D, Zhang MY, Albinson K, Kubek K, Kagan N, Beyer C, Lin Q, Dwyer JM, Zaleska MM, Bowlby MR, Dunlop J, Monaghan M. 2008. Amiloride is neuroprotective in an MPTP model of Parkinson's disease. Neurobiol Dis 31:334-341.
3. Atianjoh FE, Yaster M, Zhao X, Takamiya K, Xia J, Gauda EB, Huganir RL, Tao YX. 2010. Spinal cord protein interacting with C kinase 1 is required for the maintenance of complete Freund's adjuvant-induced inflammatory pain but not for incision-induced post-operative pain. Pain 151:226-234.
4. Bach A, Stuhr-Hansen N, Thorsen TS, Bork N, Moreira IS, Frydenvang K, Padrah S, Christensen SB, Madsen KL, Weinstein H, Gether U, Stromgaard K. 2010. Structure-activity relationships of a small-molecule inhibitor of the PDZ domain of PICK1. Org Biomol Chem 8:4281-4288.
5. Bassan M, Liu H, Madsen KL, Armsen W, Zhou J, Desilva T, Chen W, Paradise A, Brasch MA, Staudinger J, Gether U, Irwin N, Rosenberg PA. 2008. Interaction between the glutamate transporter GLT1b and the synaptic PDZ domain protein PICK1. Eur J Neurosci 27:66-82.
6. Bell JD, Park E, Ai J, Baker AJ. 2009. PICK1-mediated GluR2 endocytosis contributes to cellular injury after neuronal trauma. Cell Death Differ 16:1665-1680.
7. Bellone C, Luscher C. 2006. Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nat Neurosci 9:636-641.0.
8. Bendikov I, Nadri C, Amar S, Panizzutti R, De Miranda J, Wolosker H, Agam G. 2007. A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia. Schizophr Res 90:41-51.
9. Bertaso F, Zhang C, Scheschonka A, de Bock F, Fontanaud P, Marin P, Huganir RL, Betz H, Bockaert J, Fagni L, Lerner-Natoli M. 2008. PICK1 uncoupling from mGluR7a causes absence-like seizures. Nat Neurosci 11:940-948.
10. Bolia A, Gerek ZN, Keskin O, Banu OS, Dev KK. 2012. The binding affinities of proteins interacting with the PDZ domain of PICK1. Proteins 80:1393-1408.
11. Boudin H, Craig AM. 2001. Molecular determinants for PICK1 synaptic aggregation and mGluR7a receptor coclustering: Role of the PDZ, coiled-coil, and acidic domains. J Biol Chem 276:30270-30276.
12. Bowers MS, Chen BT, Bonci A. 2010. AMPA receptor synaptic plasticity induced by psychostimulants: The past, present, and therapeutic future. Neuron 67:11-24.
13. Cao M, Xu J, Shen C, Kam C, Huganir RL, Xia J. 2007. PICK1-ICA69 heteromeric BAR domain complex regulates synaptic targeting and surface expression of AMPA receptors. J Neurosci 27:12945-12956.
14. Coyle JT. 2006. Glutamate and schizophrenia: Beyond the dopamine hypothesis. Cell Mol Neurobiol 26:365-384.
15. Davidson ME, Kerepesi LA, Soto A, Chan VT. 2009. d-Serine exposure resulted in gene expression changes implicated in neurodegenerative disorders and neuronal dysfunction in male Fischer 344 rats. Arch Toxi0col 83:747-762.
16. Dev KK, Nakanishi S, Henley JM. 2004. The PDZ domain of PICK1 differentially accepts protein kinase C-alpha and GluR2 as interacting ligands. J Biol Chem 279:41393-41397.
17. Diochot S, Salinas M, Baron A, Escoubas P, Lazdunski M. 2007. Peptides inhibitors of acid-sensing ion channels. Toxicon 49:271-284.
18. Eriksen JL, Wszolek Z, Petrucelli L. 2005. Molecular pathogenesis of Parkinson disease. Arch Neurol 62:353-357.
19. Focant MC, Goursaud S, Boucherie C, Dumont AO, Hermans E. 2013. PICK1 expression in reactive astrocytes within the spinal cord of ALS rats. Neuropathol Appl Neurobiol 39:231-242.
20. Fujii K, Maeda K, Hikida T, Mustafa AK, Balkissoon R, Xia J, Yamada T, Ozeki Y, Kawahara R, Okawa M, Huganir RL, Ujike H, Snyder SH, Sawa A. 2006. Serine racemase binds to PICK1: Potential relevance to schizophrenia. Mol Psychiatry 11:150-157.
21. Garry EM, Moss A, Rosie R, Delaney A, Mitchell R, Fleetwood-Walker SM. 2003. Specific involvement in neuropathic pain of AMPA receptors and adapter proteins for the GluR2 subunit. Mol Cell Neurosci 24:10-22.
22. Ghasemzadeh MB, Vasudevan P, Mueller C, Seubert C, Mantsch JR. 2009. Region specific alterations in glutamate receptor expression and subcellular distribution following extinction of cocaine self-administration. Brain Res 1267:89-102.
23. Goodwin H, Curran N, Chioza B, Blower J, Nashef L, Asherson P, Makoff AJ. 2000. No association found between polymorphisms in genes encoding mGluR7 and mGluR8 and idiopathic generalised epilepsy in a case control study. Epilepsy Res 39:27-31.
24. Goursaud S, Maloteaux JM, Hermans E. 2009. Distinct expression and regulation of the glutamate transporter isoforms GLT-1a and GLT-1b in cultured astrocytes from a rat model of amyotrophic lateral sclerosis (hSOD1G93A). Neurochem Int 55:28-34.
25. Hanley JG. 2008. PICK1: A multi-talented modulator of AMPA receptor trafficking. Pharmacol Ther 118:152-160.
26. Hanley JG, Henley JM. 2005. PICK1 is a calcium-sensor for NMDA-induced AMPA receptor trafficking. EMBO J 24:3266-3278.
27. Hashimoto K, Engberg G, Shimizu E, Nordin C, Lindstrom LH, Iyo M. 2005. Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 29:767-769.
28. He Y, Liwo A, Weinstein H, Scheraga HA. 2011. PDZ binding to the BAR domain of PICK1 is elucidated by coarse-grained molecular dynamics. J Mol Biol 405:298-314.
29. Heitz F, Morris MC, Divita G. 2009. Twenty years of cell-penetrating peptides: From molecular mechanisms to therapeutics. Br J Pharmacol 157:195-206.
30. Hikida T, Mustafa AK, Maeda K, Fujii K, Barrow RK, Saleh M, Huganir RL, Snyder SH, Hashimoto K, Sawa A. 2008. Modulation of d-serine levels in brains of mice lacking PICK1. Biol Psychiatry 63:997-1000.
31. Hirbec H, Perestenko O, Nishimune A, Meyer G, Nakanishi S, Henley JM, Dev KK. 2002. The PDZ proteins PICK1, GRIP, and syntenin bind multiple glutamate receptor subtypes. Analysis of PDZ binding motifs. J Biol Chem 277:15221-15224.
32. Hohne M, Lorscheider J, von Bardeleben A, Dufner M, Scharf MA, Godel M, Helmstadter M, Schurek EM, Zank S, Gerke P, Kurschat C, Sivritas SH, Neumann-Haefelin E, Huber TB, Reinhardt HC, Schauss AC, Schermer B, Fischbach KF, Benzing T. 2011. The BAR domain protein PICK1 regulates cell recognition and morphogenesis by interacting with Neph proteins. Mol Cell Biol 31:3241-3251.
33. Hong CJ, Liao DL, Shih HL, Tsai SJ. 2004. Association study of PICK1 rs3952 polymorphism and schizophrenia. Neuroreport 15:1965-1967.
34. Ishiguro H, Koga M, Horiuchi Y, Inada T, Iwata N, Ozaki N, Ujike H, Muratake T, Someya T, Arinami T. 2007. PICK1 is not a susceptibility gene for schizophrenia in a Japanese population: association study in a large case-control population. Neurosci Res 58:145-148.
35. Jaulin-Bastard F, Saito H, Le Bivic A, Ollendorff V, Marchetto S, Birnbaum D, Borg JP. 2001. The ERBB2/HER2 receptor differentially interacts with ERBIN and PICK1 PSD-95/DLG/ZO-1 domain proteins. J Biol Chem 276:15256-15263.
36. Jiang H, Jiang Q, Feng J. 2004. Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter. J Biol Chem 279:54380-54386.
37. Jin W, Ge WP, Xu J, Cao M, Peng L, Yung W, Liao D, Duan S, Zhang M, Xia J. 2006. Lipid binding regulates synaptic targeting of PICK1, AMPA receptor trafficking, and synaptic plasticity. J Neurosci 26:2380-2390.
38. Jin W, Shen C, Jing L, Zha XM, Xia J. 2010. PICK1 regulates the trafficking of ASIC1a and acidotoxicity in a BAR domain lipid binding-dependent manner. Mol Brain 3:39.
39. Joch M, Ase AR, Chen CX, MacDonald PA, Kontogiannea M, Corera AT, Brice A, Seguela P, Fon EA. 2007. Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels. Mol Biol Cell 18:3105-3118.
40. Keifer J, Zheng Z. 2010. AMPA receptor trafficking and learning. Eur J Neurosci 32:269-277.
41. Kuner R. 2010. Central mechanisms of pathological pain. Nat Med 16:1258-1266.
42. Labrie V, Wong AH, Roder JC. 2012. Contributions of the d-serine pathway to schizophrenia. Neuropharmacology 62:1484-1503.
43. Leonard AS, Yermolaieva O, Hruska-Hageman A, Askwith CC, Price MP, Wemmie JA, Welsh MJ. 2003. cAMP-dependent protein kinase phosphorylation of the acid-sensing ion channel-1 regulates its binding to the protein interacting with C-kinase-1. Proc Natl Acad Sci USA 100:2029-2034.
44. Liu G, Shi QW, Lu GX. 2010. A newly discovered mutation in PICK1 in a human with globozoospermia. Asian J Androl 12:556-560.
45. Madsen KL, Eriksen J, Milan-Lobo L, Han DS, Niv MY, Ammendrup-Johnsen I, Henriksen U, Bhatia VK, Stamou D, Sitte HH, McMahon HT, Weinstein H, Gether U. 2008. Membrane localization is critical for activation of the PICK1 BAR domain. Traffic 9:1327-1343.
46. Maragakis NJ, Dykes-Hoberg M, Rothstein JD. 2004. Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann Neurol 55:469-477.
47. Matsuzawa D, Hashimoto K, Miyatake R, Shirayama Y, Shimizu E, Maeda K, Suzuki Y, Mashimo Y, Sekine Y, Inada T, Ozaki N, Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Hata A, Sawa A, Iyo M. 2007. Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis. Am J Psychiatry 164:1105-1114.
48. McGurk L, Bonini NM. 2012. Protein interacting with C kinase (PICK1) is a suppressor of spinocerebellar ataxia 3-associated neurodegeneration in Drosophila. Hum Mol Genet 21:76-84.
49. Meisenzahl EM, Schmitt GJ, Scheuerecker J, Moller HJ. 2007. The role of dopamine for the pathophysiology of schizophrenia. Int Rev Psychiatry 19:337-345.
50. Mikiciuk-Olasik E, Szymanski P, Zurek E. 2007. Diagnostics and therapy of Alzheimer's disease. Indian J Exp Biol 45:315-325.
51. Mustafa AK, Ahmad AS, Zeynalov E, Gazi SK, Sikka G, Ehmsen JT, Barrow RK, Coyle JT, Snyder SH, Dore S. 2010. Serine racemase deletion protects against cerebral ischemia and excitotoxicity. J Neurosci 30:1413-1416.
52. Nakamura Y, Wood CL, Patton AP, Jaafari N, Henley JM, Mellor JR, Hanley JG. 2011. PICK1 inhibition of the Arp2/3 complex controls dendritic spine size and synaptic plasticity. EMBO J 30:719-730.
53. Oliet SH, Mothet JP. 2009. Regulation of N-methyl-d-aspartate receptors by astrocytic d-serine. Neuroscience 158:275-283.
54. Palma E, Inghilleri M, Conti L, Deflorio C, Frasca V, Manteca A, Pichiorri F, Roseti C, Torchia G, Limatola C, Grassi F, Miledi R. 2011. Physiological characterization of human muscle acetylcholine receptors from ALS patients. Proc Natl Acad Sci USA 108:20184-20188.
55. Pan L, Wu H, Shen C, Shi Y, Jin W, Xia J, Zhang M. 2007. Clustering and synaptic targeting of PICK1 requires direct interaction between the PDZ domain and lipid membranes. EMBO J 26:4576-4587.
56. Parameshwaran K, Dhanasekaran M, Suppiramaniam V. 2008. Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp Neurol 210:7-13.
57. Perroy J, El Far O, Bertaso F, Pin JP, Betz H, Bockaert J, Fagni L. 2002. PICK1 is required for the control of synaptic transmission by the metabotropic glutamate receptor 7. EMBO J 21:2990-2999.
58. Pidoplichko VI, Dani JA. 2006. Acid-sensitive ionic channels in midbrain dopamine neurons are sensitive to ammonium, which may contribute to hyperammonemia damage. Proc Natl Acad Sci USA 103:11376-11380.
59. Rocca DL, Martin S, Jenkins EL, Hanley JG. 2008. Inhibition of Arp2/3-mediated actin polymerization by PICK1 regulates neuronal morphology and AMPA receptor endocytosis. Nat Cell Biol 10:259-271.
60. Rothstein JD. 2009. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65(Suppl 1):S3-S9.
61. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. 1995. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38:73-84.
62. Sansig G, Bushell TJ, Clarke VR, Rozov A, Burnashev N, Portet C, Gasparini F, Schmutz M, Klebs K, Shigemoto R, Flor PJ, Kuhn R, Knoepfel T, Schroeder M, Hampson DR, Collett VJ, Zhang C, Duvoisin RM, Collingridge GL, van Der PH. 2001. Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7. J Neurosci 21:8734-8745.
63. Sarras H, Semeralul MO, Fadel MP, Feldcamp LA, Labrie V, Wong AH. 2010. Elevated PICK1 mRNA in schizophrenia increased SRR mRNA in suicide. Schizophr Res 120:236-237.
64. Sasabe J, Chiba T, Yamada M, Okamoto K, Nishimoto I, Matsuoka M, Aiso S. 2007. d-Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis. EMBO J 26:4149-4159.
65. Shi Y, Zhang L, Yuan J, Xiao H, Yang X, Niu L. 2008. Zinc binding site in PICK1 is dominantly located at the CPC motif of its PDZ domain. J Neurochem 106:1027-1034.
66. Shi Y, Yu J, Jia Y, Pan L, Shen C, Xia J, Zhang M. 2010. Redox-regulated lipid membrane binding of the PICK1 PDZ domain. Biochemistry 49:4432-4439.
67. Shiroshima T, Oka C, Kawaichi M. 2009. Identification of LRP1B-interacting proteins and inhibition of protein kinase Calpha-phosphorylation of LRP1B by association with PICK1. FEBS Lett 583:43-48.
68. Shorvon SD. 2011. The etiologic classification of epilepsy. Epilepsia 52:1052-1057.
69. Staudinger J, Zhou J, Burgess R, Elledge SJ, Olson EN. 1995. PICK1: A perinuclear binding protein and substrate for protein kinase C isolated by the yeast two-hybrid system. J Cell Biol 128:263-271.
70. Takeya R, Takeshige K, Sumimoto H. 2000. Interaction of the PDZ domain of human PICK1 with class I ADP-ribosylation factors. Biochem Biophys Res Commun 267:149-155.
71. Thorsen TS, Madsen KL, Rebola N, Rathje M, Anggono V, Bach A, Moreira IS, Stuhr-Hansen N, Dyhring T, Peters D, Beuming T, Huganir R, Weinstein H, Mulle C, Stromgaard K, Ronn LC, Gether U. 2010. Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD. Proc Natl Acad Sci USA 107:413-418.
72. Thorsen TS, Madsen KL, Dyhring T, Bach A, Peters D, Stromgaard K, Ronn LC, Gether U. 2011. A fluorescence polarization based screening assay for identification of small molecule inhibitors of the PICK1 PDZ domain. Comb Chem High Throughput Screen 14:590-600.
73. Torres GE, Yao WD, Mohn AR, Quan H, Kim KM, Levey AI, Staudinger J, Caron MG. 2001. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30:121-134.
74. Vargas-Lopes C, Madeira C, Kahn SA, Albino do Couto I, Bado P, Houzel JC, De Miranda J, de Freitas MS, Ferreira ST, Panizzutti R. 2011. Protein kinase C activity regulates d-serine availability in the brain. J Neurochem 116:281-290.
75. Wang WL, Yeh SF, Huang EY, Lu YL, Wang CF, Huang CY, Lin WJ. 2007. Mitochondrial anchoring of PKCalpha by PICK1 confers resistance to etoposide-induced apoptosis. Apoptosis 12:1857-1871.
76. Wang W, Petralia RS, Takamiya K, Xia J, Li YQ, Huganir RL, Tao YX, Yaster M. 2011. Preserved acute pain and impaired neuropathic pain in mice lacking protein interacting with C Kinase 1. Mol Pain 7:11.
77. Williams JM, Galli A. 2006. The dopamine transporter: A vigilant border control for psychostimulant action. Handb Exp Pharmacol 175:215-232.
78. Wolf ME. 2010. Regulation of AMPA receptor trafficking in the nucleus accumbens by dopamine and cocaine. Neurotox Res 18:393-409.
79. Xiao N, Kam C, Shen C, Jin W, Wang J, Lee KM, Jiang L, Xia J. 2009. PICK1 deficiency causes male infertility in mice by disrupting acrosome formation. J Clin Invest 119:802-812.
80. Xiong ZG, Pignataro G, Li M, Chang SY, Simon RP. 2008. Acid-sensing ion channels (ASICs) as pharmacological targets for neurodegenerative diseases. Curr Opin Pharmacol 8:25-32.
81. Xu J, Xia J. 2006. Structure and function of PICK1. Neurosignals 15:190-201.
82. Yu DF, Wu PF, Fu H, Cheng J, Yang YJ, Chen T, Long LH, Chen JG, Wang F. 2011. Aging-related alterations in the expression and distribution of GluR2 and PICK1 in the rat hippocampus. Neurosci Lett 497:42-45.
83. Zhuang Z, Yang B, Theus MH, Sick JT, Bethea JR, Sick TJ, Liebl DJ. 2010. EphrinBs regulate d-serine synthesis and release in astrocytes. J Neurosci 30:16015-16024.